Q2 2022 Jazz Pharmaceuticals PLC Earnings Call Transcript
Ladies and gentlemen, thank you for standing by, and welcome to the Second Quarter 2022 Jazz Pharmaceuticals Earnings Call. (Operator Instructions) I would now like to turn the call over to your host, Andrea Flynn, Vice President, Head of Investor Relations. You may begin.
Thank you, and good afternoon, everyone. Today, Jazz Pharmaceuticals reported its second quarter 2022 financial results. The slide presentation accompanying this webcast is available on the Investors section of our website. Investors may also refer to the press release we issued earlier today, which is also posted on our website.
On the call today are Bruce Cozadd, Chairman and Chief Executive Officer; Renee Gala, Executive Vice President and Chief Financial Officer; Dan Swisher, President; and Rob Iannone, Executive Vice President, Global Head of R&D; Kim Sablich, Executive Vice President and General Manager, North America, will join the team for Q&A.
On Slide 2, I'll remind you that today's webcast
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |